Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Xuebin
Xuebin Liu, Pudong CN
| Patent application number | Description | Published |
|---|---|---|
| 20100040616 | TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASE - The present invention provides novel methods of treatment of multiple sclerosis and other autoimmune diseases or inflammatory disorders, and antagonists, including isolated binding proteins for use in the novel methods. There is provided a method of treating multiple sclerosis comprising the neutralization of the biological activity of IL-7 by binding to CD127 or IL-7. The isolated binding proteins may also neutralize the biological activity of TSLP. | 02-18-2010 |
Xuebin Liu, Guangzhou City CN
| Patent application number | Description | Published |
|---|---|---|
| 20110118462 | N-HETEROCYCLIC SUBSTITUENT-CONTAINING ANTIBIOTIC, PREPARATION AND USE THEREOF - The invention relates to N-heterocyclic substituent-containing antibiotics, their preparation, and their use. Disclosed are sodium and potassium salts of 7-(α-((N,N′-diisopropylamidino)thio)acetylamino)-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl) cephalosporanic acid as presented by the general structure (I), their preparation, and their use. The antibiotics of the invention can be used to treat diseases caused by Gram-positive or Gram-negative bacteria such as septicaemia, gastrointestinal tract infection, and urinary tract infection. They have increased half-life in blood and lowered toxicity. They can reduce the frequency of drug use and lower medical treatment costs. They have improved stability and can be stored at ambient temperatures. The method of the invention is simple, and it produces high purity products which can meet the requirements of clinical use. | 05-19-2011 |
Xuebin Liu, Shanghai CN
| Patent application number | Description | Published |
|---|---|---|
| 20110287000 | TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASE - The present invention provides novel methods of treatment of multiple sclerosis and other autoimmune diseases or inflammatory disorders, and antagonists, including isolated binding proteins for use in the novel methods. There is provided a method of treating multiple sclerosis comprising the neutralization of the biological activity of IL-7 by binding to CD127 or IL-7. The isolated binding proteins may also neutralize the biological activity of TSLP. | 11-24-2011 |
Xuebin Wu, Shenzhen CN
| Patent application number | Description | Published |
|---|---|---|
| 20130031351 | Multi-Mode Data Card and Calibrating Method Thereof - A multi-mode data card includes at least two mode modules, and also includes an external interface module and an interface control module. The external interface module connects to the interface control module. The external interface is configured to connect with computer for data interaction; the interface control module is equipped with at least two channels, and said at least two channels connects to said at least two mode modules respectively. The interface control module is configured to: when the multi-mode data card is calibrated, connect the external interface module with the channel corresponding to the mode module to be calibrated, and switch the multi-mode data card to the mode to be calibrated. A method for calibrating multi-mode data card is also provided in the present invention. | 01-31-2013 |
Xuebin Zhao, Hebei CN
| Patent application number | Description | Published |
|---|---|---|
| 20120095209 | INTERMEDIATE OF ERTAPENEM, A COMPOSITION COMPRISING THE SAME AND PREPARATION METHODS THEREOF - Intermediates of Ertapenem of formula 2a wherein Np represents (I) or (II), and P | 04-19-2012 |